AMRX - Amneal stock climbs on Q1 report opioid settlement update
2024-05-03 15:45:56 ET
More on Amneal Pharmaceuticals
- Amneal Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
- Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript
- Amneal Pharmaceuticals, Inc. (AMRX) Q4 2023 Earnings Call Transcript
- Amneal Pharmaceuticals Non-GAAP EPS of $0.14 beats by $0.05, revenue of $659M beats by $39.97M
- Amneal Pharmaceuticals Q1 2024 Earnings Preview